SEC Form 4 · accession 0000940805-26-000004
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Norman D Schwartz
Officer — Chairman & CEO · Director · 10% Owner
Period of report
Sep 4, 2026
Accepted (ET)
Sep 9, 2026 · 6:42 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad A Common StockF1 | Sep 5, 2026 | M | 4,109 | $0.00 | A | 450,294 | D | |
| Bio-Rad A Common Stock | Sep 5, 2026 | F | 2,876 | $386.11 | D | 447,418 | D | |
| Bio-Rad A Common StockF1 | Sep 6, 2026 | M | 3,455 | $0.00 | A | 450,873 | D | |
| Bio-Rad A Common Stock | Sep 6, 2026 | F | 1,854 | $386.11 | D | 449,019 | D | |
| Bio-Rad B Common Stock | holding | — | — | — | 361,466 | D | ||
| Bio-Rad B Common StockF2 | holding | — | — | — | 13,006 | I | By Spouse | |
| Bio-Rad B Common StockF3 | holding | — | — | — | 4,060,054 | I | By Blue Raven Partners, L.P. | |
| Bio-Rad A Common StockF4 | holding | — | — | — | 1,781,356 | I | By Alice N. Schwartz Revocable Trust | |
| Bio-Rad A Common StockF4 | holding | — | — | — | 90 | I | By David Schwartz Exemption Trust | |
| Bio-Rad A Common StockF4 | holding | — | — | — | 240 | I | By David Schwartz Exempt Martial Trust | |
| Bio-Rad A Common StockF4 | holding | — | — | — | 898,931 | I | By David Schwartz Non-Exempt Martial Trust | |
| Bio-Rad B Common StockF4 | holding | — | — | — | 57,000 | I | By David Schwartz Non-Exempt Martial Trust | |
| Bio-Rad A Common StockF4 | holding | — | — | — | 34,311 | I | By Charitable Remainder Unitrust | |
| Bio-Rad B Common StockF4 | holding | — | — | — | 437,510 | I | By Alice N. Schwartz Revocable Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF5,F6 | $0.00 | Sep 4, 2026 | A | 17,251 | A | — | — | Bio-Rad A Common Stock | 17,251 | 17,251 | D |
| Restricted Stock UnitsF5,F7 | $0.00 | Sep 5, 2026 | M | 4,109 | D | — | — | Bio-Rad A Common Stock | 4,109 | 12,330 | D |
| Restricted Stock UnitsF5,F7 | $0.00 | Sep 6, 2026 | M | 3,455 | D | — | — | Bio-Rad A Common Stock | 3,455 | 6,912 | D |
Explanation of responses
- F1Shares of Class A common stock acquired on the vesting of restricted stock units.
- F2The reporting person disclaims beneficial ownership of these shares.
- F3The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- F4The shares are held by in trust of which the reporting person serves as the trustee. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- F5Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- F6The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter.
- F7The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.